Callisto has a well-respected research and management team with many years of experience in the pharmaceutical and biotechnology industry. Members of the management team have particular experience in the development of anti-cancer agents, including the platinum anticancer drug ParaplatinTM and genasense. The team has specialized in early stage research and development, having successfully identified and developed preclinical drug canidates and brought them to the clinic. The management team was also responsible for preclinical discovery of UT231B, a drug currently in human testing for hepatitis C by United Therapeutics.
